Overview

Latest Investor Information

September 13, 2016

Medtronic plc at the Morgan Stanley Global Healthcare Conference

September 08, 2016

Medtronic plc at the 2016 Wells Fargo Healthcare Conference

August 25, 2016

Q1 2017 Medtronic plc Earnings Conference Call

June 12, 2016

Medtronic Analyst Briefing at ADA

June 06, 2016

Medtronic plc Investor and Analyst Meeting

Latest Press Releases

September 26, 2016	Medtronic's StealthStation® Cranial Software Receives FDA Clearance as an Aid for Deep Brain Stimulation Lead Placement
September 20, 2016	Medtronic Valiant Captivia Demonstrates Safety and Efficacy at Three Years
September 19, 2016	New Data Presented in VIVA Late Breaking Clinical Trials Demonstrate Durability, Safety and Efficacy for the Medtronic In.Pact Admiral DCB
September 19, 2016	Analysis Shows Positive Association Between Cardiac Resynchronization Therapy and Patients' Increased Adherence to Heart Failure Medication Regimens

Tax Treatment

Dividend Distribution U.S. Tax Treatment

Opportunities to Obtain Irish Dividend Withholding Tax (DWT) Exemption

Important Information on the Irish Dividend Withholding Tax.

QUARTERLY

RESULTS

Medtronic Q1 revenue results and financial tables.

INVESTOR

FUNDAMENTALS

View snapshots of revenue and earnings, trading statistics, balance sheet, income statement, cash flow and ratios.

Sustainability Index Endorsements

Read more about our Sustainability efforts.

Medtronic Spotlight

CNBC’s Meg Tirrell talks to Medtronic CEO Omar Ishrak at the Piper Jaffray Healthcare Heartland Summit about growth, pricing and other challenges facing the industry.

Play Video